Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Melatonin has beneficial effects on sleep quality and Hb1Ac in type 2 diabetics

July 9, 2001

Naftidrofuryl effective and safe in patients with vascular or mixed dementia

July 9, 2001

Safe intracerebroventricular doses of huperzine A determined in animals

July 9, 2001

Heterocyclic compounds with activity at alpha1-adrenoceptors and several 5-HT receptors

July 9, 2001

Novartis sells rights to five CNS products to Mallinckrodt

July 9, 2001

Positive Seroquel data presented at Conference on Bipolar Disorder

July 9, 2001

Phytoestrogens attenuate Abeta-mediated neuronal toxicity

July 6, 2001

New study data support lamotrigine as treatment for bipolar disorder

July 6, 2001

Pharmacological profile of AS-8112 suggests potential in emesis

July 6, 2001

Role for donepezil in the prophylaxis of migraine

July 6, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...